Press release
What's Driving the Acute Intermittent Porphyria Market 2025-2034: Impact Of Rising Metabolic Disorders On The Growth Of The Acute Intermittent Porphyria Market
Acute Intermittent Porphyria Market Size
There has been a robust growth in the market size of acute intermittent porphyria in the past few years. The market that was valued at $4.37 billion in 2024, is projected to increase to $4.66 billion in 2025, marking a compound annual growth rate (CAGR) of 6.7%. Factors such as increasing healthcare spending, a surge in the biopharmaceuticals market, growing incidence of genetic disorders, widened scope of telemedicine services, and an emphasis on early diagnosis can be attributed to this growth in the historical period.
The market for acute intermittent porphyria is projected to experience significant expansion in the upcoming years, reaching $5.96 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 6.3%. Several factors are anticipated to drive this growth throughout the forecast period, including the rising number of acute intermittent porphyria cases, heightened awareness of rare diseases, favorable government policies, increased patient advocacy, and the growth of genetic testing services. Key trends during this time frame are expected to include advancements in diagnostic procedures, the creation of innovative therapeutic approaches, increased investment in R&D, partnerships among pharmaceutical companies, and technological advancements in treatments.
What Are the Main Catalysts for Growth in the Acute Intermittent Porphyria Market?
The increasing instances of metabolic disorders are anticipated to stimulate the expansion of the acute intermittent porphyria market. Metabolic disorders, a set of conditions emerging from unusual chemical reactions in the body that interfere with regular metabolic processes, are attributed to genetic factors, lifestyle elements, environmental impact, and heightened consciousness and diagnosis. The pharmaceutical industry is motivated by this surge of metabolic disorders to focus on treatment options for rare and genetic conditions, such as acute intermittent porphyria. Cleveland Clinic, a US-based nonprofit academic medical centre, reported in December 2023, that inherited metabolic disorders affect around 1 in 1,000 to 2,500 births globally. Consequently, the increasing prevalence of metabolic disorders is propelling the acute intermittent porphyria market's growth.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19264&type=smp
Which Businesses Are at the Forefront of Acute Intermittent Porphyria Market Development?
Major companies operating in the acute intermittent porphyria market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Sanofi SA, AstraZeneca Plc, Novartis AG, GlaxoSmithKline Plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Novo Nordisk A/S, Regeneron Pharmaceuticals Inc., Daiichi Sankyo Company Limited, Vertex Pharmaceuticals Inc., Eisai Co. Ltd., Octapharma AG, BioMarin Pharmaceutical Inc., Swedish Orphan Biovitrum AB, Alnylam Pharmaceuticals Inc., Mylan N.V., Clinuvel Pharmaceuticals Ltd., Recordati Rare Diseases Inc.
What Are the Latest Innovations in the Acute Intermittent Porphyria Market?
Prominent firms in the acute intermittent porphyria market are prioritizing the development of groundbreaking products such as acute intermittent porphyria management tablets, aiming to serve consumers with enhanced functionalities better. These tablets are oral drugs used for managing or preventing the symptoms and acute attacks linked with AIP. For example, Alembic Pharmaceuticals Ltd., an Indian pharmaceutical firm, publicized in October 2023 that the US Food & Drug Administration (USFDA) approved its Chlorpromazine Hydrochloride Tablets USP available in 10 mg, 25 mg, 50 mg, 100 mg, and 200 mg dosages. The Chlorpromazine hydrochloride tablets USP, offered in the above doses, are employed for managing psychotic disorders symptoms and treating schizophrenia. The tablets also control nausea and vomiting, relieve pre-surgery restlessness and anxiety, and assist as an adjunct in treating tetanus. Moreover, these tablets are used for managing acute intermittent porphyria, regulating manic-depressive illness' manic symptoms, and providing relief from relentless hiccups.
How Is the Acute Intermittent Porphyria Market Segmented?
The acute intermittent porphyriamarket covered in this report is segmented -
1) By Diagnosis: Urine Test, Blood Test, Serum Test, DNA Test, Other Diagnosis
2) By Treatment: Prophylactic Hematin Infusions, Gonadotropin-Releasing Hormone Analogues, Other Treatments
3) By End-Users: Hospitals And Clinics, Ambulatory Surgical Centers, Research Centers
Subsegments:
1) By Urine Test: Urine Porphobilinogen (PBG) Test, Urine Aminolevulinic Acid (ALA) Test, Urine Color Change Test
2) By Blood Test: Plasma Porphyrin Levels Test, Blood Aminolevulinic Acid (ALA) Test, Complete Blood Count (CBC) Test
3) By Serum Test: Serum Porphyrin Levels Test, Liver Function Test (LFT), Serum ALA and PBG Enzyme Test
4) By DNA Test: Genetic Mutation Testing, Gene Sequencing Test
5) By Other Diagnosis: Stool Test for Porphyrins, Imaging Tests (CT/MRI Scans for Complications), Enzyme Activity Assays.
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/acute-intermittent-porphyria-global-market-report
Where Is the Acute Intermittent Porphyria Market Growth Most Prominent?
North America was the largest region in the acute intermittent porphyria market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acute intermittent porphyria market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Is Covered In The Acute Intermittent Porphyria Global Market Report?
- Market Size Analysis: Analyze the Acute Intermittent Porphyria Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Acute Intermittent Porphyria Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Acute Intermittent Porphyria Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Acute Intermittent Porphyria Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19264
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release What's Driving the Acute Intermittent Porphyria Market 2025-2034: Impact Of Rising Metabolic Disorders On The Growth Of The Acute Intermittent Porphyria Market here
News-ID: 3866088 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Test
Key Differences Between Megger Test, Tan Delta Test, and Hi-Pot Test for Electri …
Electrical insulation plays a critical role in ensuring the safety and efficiency of electrical systems. To assess the condition of insulation and identify potential issues, three common tests are used: the Megger test, Tan Delta test, and Hi-Pot test. Each test serves a unique purpose and provides valuable insights into the state of electrical insulation. Here's a closer look at the differences between these three essential tests.
Megger Test: Insulation Resistance…
Vitamin Test Market: Global Vitamin Test Analysis and Forecast (2023-2029)Vitami …
12.04.2024: Vitamin Test Market Overview
The development of companion diagnostic tools and advances in personalised treatment are driving considerable growth and revolution in the oncology Vitamin Test market. In the era of precision medicine, where healthcare is increasingly customised for individual individuals based on their own genetic and molecular profiles, this market segment is essential. Ongoing innovation and development define the oncology Vitamin Test market. To find particular biomarkers, genetic mutations,…
CAGR 8.1% Homecare Pregnancy Test Kits Market By Type of Test (Urine Test For H …
The Homecare Pregnancy Test Kits market report by Reports and Data provides an extensive overview of the vital elements of the Homecare Pregnancy Test Kits market and factors such as the drivers, restraints, latest trends, supervisory scenario, competitive landscape, technological advancements, and others. Further, it mentions the market shares associated with the market in terms of both value and volume along with the segmentation. Space-age industrial and digitalization tools are…
Home Safety Test Kits Market, Home Safety Test Kits Market Trends, Home Safety T …
“Home Safety Test Kits Market” 2020-2025 Research Report is a professional and in-depth study on the current state of the market. Global Home Safety Test Kits market containing a complete view of the market size, business share, profit estimates, SWOT analysis and the regional landscape of the Industry. The report explains key challenges and future development prospects of the market. The Global Home Safety Test Kits analysis is provided for…
Test Data Management (TDM) Market - test data profiling, test data planning, tes …
The report categorizes the global Test Data Management (TDM) market by top players/brands, region, type, end user, market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
This report studies the global market size of Test Data Management (TDM) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption…
Hearing Screening and Diagnostic Devices Market Demands with Major Tests: pure T …
New Market Research Reports Title "Hearing Screening And Diagnostic Devices Market 2018" Has Been Added to Crystal Market Research Report database.
Hearing Screening and Diagnostic Devices - Competitive Insights:
The leading players in the market are Gn Otometrics A/S, Otodynamics, Nashua Hearing Group, Siemens Healthineers, Natus Medical Incorporated, Interacoustics A/S, Neurosoft S.A, Accent Hearing Pty Ltd, MAICO Diagnostics GmbH and IntriCon Corporation. The major players in the market are profiled in detail…
